Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

A completed Phase 1 clinical trial evaluating safety, tolerability, PK, and PD of CB06-036 in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• CB06-036

Snippet

Sponsor: Shanghai Zhimeng Biopharma, Inc. | Conditions: Chronic Hepatitis b | Phase 1 | Status: COMPLETED